Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
Clinical trial NCT03908840 · UNKNOWN
Trial details
- NCT number
- NCT03908840
- Sponsor
- Evolve Biologics
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.